Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120
- PMID: 8510207
- PMCID: PMC237746
- DOI: 10.1128/JVI.67.7.3818-3825.1993
Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120
Abstract
The mechanism of CD4-mediated fusion via activated human immunodeficiency virus type 1 (HIV-1) gp41 and the biological significance of soluble CD4 (sCD4)-induced shedding of gp120 are poorly understood. The purpose of these investigations was to determine whether shedding of gp120 led to fusion activation or inactivation. BJAB cells (TF228.1.16) stably expressing HIV-1 envelope glycoproteins (the gp120-gp41 complex) were used to examine the effects of pH and temperature on sCD4-induced shedding of gp120 and on cell-to-cell fusion (syncytium formation) with CD4+ SupT1 cells. sCD4-induced shedding of gp120 was maximal at pH 4.5 to 5.5 and did not occur at pH 8.5. At physiologic pH, sCD4-induced shedding of gp120 occurred at 22, 37, and 40 degrees C but neither at 16 nor 4 degrees C. In contrast, syncytia formed at pH 8.5 (maximally at pH 7.5) but not at pH 4.5 to 5.5. At pH 7.5, syncytia formed at 37 and 40 degrees C but not at 22, 16, or 4 degrees C. Preincubation of cocultures of TF228.1.16 and SupT1 cells at 4, 16, or 22 degrees C before the shift to 37 degrees C resulted in similar, increased, or decreased syncytium formation, respectively, compared with the control. Furthermore, an activated intermediate of CD4-gp120-gp41 ternary complex may form at 16 degrees C; this intermediate rapidly executes fusion upon a shift to 37 degrees C but readily decays upon a shift to the shedding-permissive but fusion-nonpermissive temperature of 22 degrees C. These physicochemical data indicate that shedding of HIV-1 gp120 is not an integral step in the fusion cascade and that CD4 may inactivate the fusion complex in a process analogous to sCD4-induced shedding of gp120.
Similar articles
-
Characterization of CD4-gp120 activation intermediates during human immunodeficiency virus type 1 syncytium formation.AIDS Res Hum Retroviruses. 1996 Sep 20;12(14):1305-13. doi: 10.1089/aid.1996.12.1305. AIDS Res Hum Retroviruses. 1996. PMID: 8891109
-
Correlation between kinetics of soluble CD4 interactions with HIV-1-Env-expressing cells and inhibition of syncytia formation: implications for mechanisms of cell fusion and therapy for AIDS.AIDS. 1992 Mar;6(3):249-56. doi: 10.1097/00002030-199203000-00001. AIDS. 1992. PMID: 1348943
-
Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.J Virol. 1992 Jan;66(1):132-8. doi: 10.1128/JVI.66.1.132-138.1992. J Virol. 1992. PMID: 1727475 Free PMC article.
-
CD4 activation of HIV fusion.Int J Cell Cloning. 1992 Nov;10(6):323-32. doi: 10.1002/stem.5530100603. Int J Cell Cloning. 1992. PMID: 1281202 Review.
-
The role of CD4 in HIV binding and entry.Philos Trans R Soc Lond B Biol Sci. 1993 Oct 29;342(1299):59-66. doi: 10.1098/rstb.1993.0136. Philos Trans R Soc Lond B Biol Sci. 1993. PMID: 7904348 Review.
Cited by
-
Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation.J Exp Med. 1996 Feb 1;183(2):473-84. doi: 10.1084/jem.183.2.473. J Exp Med. 1996. PMID: 8627160 Free PMC article.
-
Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants.J Virol. 2001 Mar;75(5):2041-50. doi: 10.1128/JVI.75.5.2041-2050.2001. J Virol. 2001. PMID: 11160708 Free PMC article.
-
Mechanisms of enveloped virus entry into animal cells.Adv Drug Deliv Rev. 1998 Oct 5;34(1):65-91. doi: 10.1016/s0169-409x(98)00002-7. Adv Drug Deliv Rev. 1998. PMID: 10837671 Free PMC article.
-
Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates.J Virol. 1995 Jul;69(7):4413-22. doi: 10.1128/JVI.69.7.4413-4422.1995. J Virol. 1995. PMID: 7769703 Free PMC article.
-
A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7287-92. doi: 10.1073/pnas.95.13.7287. Proc Natl Acad Sci U S A. 1998. PMID: 9636141 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials